Last updated on October 2018

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)


Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

London North West Healthcare N /ID# 145953
Harrow, United Kingdom
0.13miles
  Connect »

ABBVIE CALL CENTER

Imperial College Healthcare /ID# 145916
London, United Kingdom
7.43miles
  Connect »